How adults with treatment resistant depression experience their first esketamine nasal spray treatment? Preliminary results from a French qualitative study

Introduction Spravato® (esketamine nasal spray- ENS) is a new adjunctive drug for Treatment Resistant Depression (TRD), i.e. patients with major depressive disorder that failed to adequately respond despite the use of two different antidepressants. In France, a real world non-interventional post-c...

Descripció completa

Dades bibliogràfiques

Autors principals:	E. Manolios, J. Mathé, J. Sibeoni, M. Rotharmel, B. Astruc, B. Falissard, L. Mekaoui, A. Laurin, E. Gaudre-Wattinne, J. Dupin, A. Revah-Levy
Format:	Artigo
Idioma:	Inglês
Publicat:	Cambridge University Press 2024-04-01
Col·lecció:	European Psychiatry
Accés en línia:	https://www.cambridge.org/core/product/identifier/S0924933824002530/type/journal_article
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!